CVA Family Office’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$13.6K Buy
150
+90
+150% +$8.26K ﹤0.01% 902
2025
Q4
$5.39K Sell
60
-89
-60% -$8.44K ﹤0.01% 878
2025
Q3
$14.7K Buy
149
+39
+35% +$3.87K ﹤0.01% 749
2025
Q2
$10K Sell
110
-75
-41% -$7.25K ﹤0.01% 800
2025
Q1
$20.9K Sell
185
-18
-9% -$1.93K ﹤0.01% 675
2024
Q4
$21.4K Buy
203
+118
+139% +$12.7K ﹤0.01% 665
2024
Q3
$9.18K Sell
85
-85
-50% -$9.28K ﹤0.01% 768
2024
Q2
$18.4K Buy
170
+81
+91% +$9.55K ﹤0.01% 654
2024
Q1
$11.7K Buy
89
+4
+5% +$500 ﹤0.01% 724
2023
Q4
$10.3K Buy
+85
New +$9.48K ﹤0.01% 721
2023
Q3
Sell
-95
Closed -$13.8K 987
2023
Q2
$13.8K Buy
95
+5
+6% +$679 ﹤0.01% 674
2023
Q1
$11.6K Sell
90
-10
-10% -$1.26K ﹤0.01% 672
2022
Q4
$12.8K Buy
100
+15
+18% +$1.74K ﹤0.01% 630
2022
Q3
$9K Sell
85
-160
-65% -$17.6K ﹤0.01% 650
2022
Q2
$26K Hold
245
0.01% 497
2022
Q1
$31K Sell
245
-146
-37% -$17.6K 0.01% 492
2021
Q4
$48K Buy
+391
New +$51.2K 0.01% 370
2021
Q3
Sell
-77
Closed -$12K 908
2021
Q2
$12K Sell
77
-26
-25% -$4.21K ﹤0.01% 623
2021
Q1
$16K Buy
+103
New +$16K 0.01% 456

Other funds holding ZBH

CVA Family Office's ZBH Position: Q1 2026 in Review

CVA Family Office increased its Zimmer Biomet (ZBH) stake by 150% in Q1 2026, buying an estimated $8.26K and bringing the position to 150 shares worth $13.6K. The position accounts for ﹤0.01% of the portfolio, ranked #902.

CVA Family Office first reported a position in ZBH in Q1 2021 and has held it in 19 quarters since. The position peaked at $48K in Q4 2021. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • CVA Family Office held 150 shares of Zimmer Biomet worth $13.6K as of Q1 2026.
  • CVA Family Office bought 90 Zimmer Biomet shares in Q1 2026, an estimated $8.26K.
  • Zimmer Biomet made up ﹤0.01% of CVA Family Office's portfolio in Q1 2026, its #902 holding.
  • CVA Family Office first reported a position in Zimmer Biomet in Q1 2021 and has held it in 19 quarters since.
  • CVA Family Office's Zimmer Biomet position peaked at $48K in Q4 2021.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on CVA Family Office's 13F filing for Q1 2026, filed 29 Apr 2026.